PMID: 9189676Jul 1, 1997Paper

Laser treatment of acquired vascular lesions

Dermatologic Clinics
B S RossRobin Ashinoff

Abstract

Several quasi-continuous wave and pulsed lasers can effectively treat a variety of vascular lesions. The PDL follows the theory of selective photothermolysis, is safe for infants and children, and has a low incidence of side effects. It is successful in treating telangiectasias, spider and cherry angiomas, pyogenic granulomas, venous lakes, and poikiloderma of Civatte, as well as small leg telangiectasias. Quasi-continuous wave lasers such as the APTDL, copper vapor, krypton, and KTP lasers can be used to treat telangiectasias and other vascular lesions as well. Although they carry a higher risk of complications, they may prove more useful in treating larger caliber vessels. Although the PDL often produces superior clinical results than the quasi-continuous wave lasers, some patients may prefer these latter lasers because of the lack of post-operative purpura. Lastly, newer lasers, as well as noncoherent light sources, are being developed for the treatment of leg telangiectasias. Continuing advances in laser technology will enhance results, decrease side effects, improve equipment, and reduce costs, with great benefit to an increasing patient population.

References

Oct 1, 1992·Journal of the American Academy of Dermatology·J W TapperoT G Berger
Aug 1, 1992·Journal of the American Academy of Dermatology·E GonzalezK T Momtaz
May 1, 1992·Archives of Otolaryngology--head & Neck Surgery·J M Key, M Waner
May 1, 1992·The Journal of Dermatologic Surgery and Oncology·M P Goldman
May 1, 1992·The Journal of Dermatologic Surgery and Oncology·R R Anderson
Nov 1, 1991·Journal of the American Academy of Dermatology·J M Swinehart
Dec 1, 1991·The Journal of Dermatologic Surgery and Oncology·D J Goldberg, C W Sciales
Jan 1, 1990·The Journal of Dermatologic Surgery and Oncology·R G Wheeland, J Applebaum
Apr 1, 1990·Archives of Dermatology·R Geronemus
Apr 1, 1990·The Journal of Dermatologic Surgery and Oncology·M P Goldman, R E Fitzpatrick
Mar 1, 1990·Clinical and Experimental Dermatology·R A Neumann, R M Knobler
May 1, 1990·British Journal of Plastic Surgery·J W PickeringC N van Halewyn
Dec 1, 1989·Journal of the American Academy of Dermatology·R D BlickenstaffJ R Goellner
Nov 1, 1988·The Journal of Dermatologic Surgery and Oncology·E GlassbergJ Uitto
Aug 1, 1987·Journal of the American Academy of Dermatology·M P Goldman, R G Bennett
May 1, 1987·The Journal of Dermatologic Surgery and Oncology·M P GoldmanD M Duffy
Apr 1, 1982·Archives of Dermatology·K A Arndt
Jan 1, 1984·Lasers in Surgery and Medicine·O T TanJ A Parrish
Jan 1, 1984·Plastic and Reconstructive Surgery·M LandthalerO Braun-Falco
Jan 1, 1995·Clinics in Dermatology·G P Lask, E Glassberg
Mar 1, 1995·Seminars in Dermatology·K F Rothman
May 1, 1995·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·R G Geronemus
Dec 1, 1994·The Journal of Dermatologic Surgery and Oncology·P BoixedaA Ledo
Nov 1, 1994·The Journal of Dermatologic Surgery and Oncology·P BroskaM M Goodman
Apr 1, 1994·Annals of Plastic Surgery·D B Apfelberg
Nov 1, 1993·Journal of the American Academy of Dermatology·S J HoffmanJ G Morelli
Nov 1, 1993·The Journal of Dermatologic Surgery and Oncology·J Ruiz-EsparzaK L Behr
Nov 1, 1993·The Journal of Dermatologic Surgery and Oncology·M WanerS T Flock
Jan 1, 1994·The Journal of Dermatologic Surgery and Oncology·P K Thibault
Oct 1, 1993·The Journal of Dermatologic Surgery and Oncology·M P GoldmanR E Fitzpatrick
Apr 1, 1993·The Journal of Dermatologic Surgery and Oncology·R G Geronemus
Apr 1, 1993·The Journal of Dermatologic Surgery and Oncology·J M Garden, A D Bakus
Apr 1, 1993·The Journal of Dermatologic Surgery and Oncology·S M DinehartS Flock
Apr 1, 1996·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·D H McDanielM Zukowski
Jun 1, 1996·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·S McCoyM Repacholi

❮ Previous
Next ❯

Citations

Aug 22, 2000·The British Journal of Dermatology·K M Acland, R J Barlow
Mar 1, 2002·The Australasian Journal of Dermatology·Greg J GoodmanAlex Bezborodoff
Sep 6, 2000·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·R A WeissM A Weiss
Dec 11, 2002·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Robert A WeissKaren L Beasley
May 4, 2001·Plastic and Reconstructive Surgery·M P Goldman, R A Weiss
Feb 12, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·R NoborioA Morita
Oct 26, 2006·Journal of the European Academy of Dermatology and Venereology : JEADV·M M MeijsM A de Rie
Jun 17, 2014·The Journal of Dermatology·Kanako TsunodaToshihide Akasaka
Jan 30, 2003·Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology·P BjerringA Troilius

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.